APA (7th ed.) Citation

Fang, X., Shu, L., Chen, T., Zhao, X., Yang, L., Dou, T., . . . Feng, M. (2024). Organoids derived from patients provide a new opportunity for research and individualized treatment of malignant peritoneal mesothelioma. Molecular Cancer, 23(1), 1. https://doi.org/10.1186/s12943-023-01901-z

Chicago Style (17th ed.) Citation

Fang, XiaoChang, Lin Shu, TianLiang Chen, XiaoLe Zhao, LiuCui Yang, Tingting Dou, Lijie Yang, Xuanfei Li, and Maohui Feng. "Organoids Derived from Patients Provide a New Opportunity for Research and Individualized Treatment of Malignant Peritoneal Mesothelioma." Molecular Cancer 23, no. 1 (2024): 1. https://doi.org/10.1186/s12943-023-01901-z.

MLA (9th ed.) Citation

Fang, XiaoChang, et al. "Organoids Derived from Patients Provide a New Opportunity for Research and Individualized Treatment of Malignant Peritoneal Mesothelioma." Molecular Cancer, vol. 23, no. 1, 2024, p. 1, https://doi.org/10.1186/s12943-023-01901-z.